Skip to content

PLOS is a non-profit organization on a mission to drive open science forward with measurable, meaningful change in research publishing, policy, and practice.

Building on a strong legacy of pioneering innovation, PLOS continues to be a catalyst, reimagining models to meet open science principles, removing barriers and promoting inclusion in knowledge creation and sharing, and publishing research outputs that enable everyone to learn from, reuse and build upon scientific knowledge.

We believe in a better future where science is open to all, for all.

PLOS BLOGS Speaking of Medicine and Health

This Week in PLoS Medicine: WHO retreatment for TB; HRT promotions; GRIPS Statement

Image Credit: Nate Steiner

Five new articles were published this week in PLoS Medicine, including two Perspectives, providing an expert’s view on research articles.

A prospective evaluation of the effectiveness of the WHO-recommended standardized retreatment regimen for tuberculosis by Edward Jones-López and colleagues reveals an unacceptable proportion of unsuccessful outcomes. An accompanying Perspective by Jerome Singh discusses the ethical issues that the study raises.

Adriane Fugh-Berman and colleagues analyzed a selection of published opinion pieces on hormone therapy and show that there may be a connection between receiving industry funding for speaking, consulting, or research and the tone of such opinion pieces.

Cecile Janssens and colleagues present the GRIPS Statement, a checklist to help improve the reporting of genetic risk prediction studies.

K. Srinath Reddy discusses last week’s research study by S. V. Subramanian and colleagues that found no strong evidence of recent economic growth in India being associated with a reduction in child undernutrition.

Remember you can comment on, annotate and rate any PLoS Medicine article and see the views, citations and other indications of impact of an article on that articles metrics tab.

Back to top